Wockhardt locks in 5% upper circuit as it nears approval for pneumonia drug ...Middle East

Business Standard - Economy
Wockhardt locks in 5% upper circuit as it nears approval for pneumonia drug
A positive response from CDSCO will give a push to the company efforts to gain the Drugs Controller General of India's (DCGI) final approval for Miqnaf

Hence then, the article about wockhardt locks in 5 upper circuit as it nears approval for pneumonia drug was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Wockhardt locks in 5% upper circuit as it nears approval for pneumonia drug )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in Economy


Latest News